Stephen Allen Hurly

Stephen Allen Hurly

Chief Executive Officer presso LAVA THERAPEUTICS N.V.

Patrimonio netto: 16 650 $ in data 31/03/2024

56 anni
Finance
Health Technology
Consumer Services

Provenienza dei contatti di primo grado di Stephen Allen Hurly

EntitàTipo di entitàSettore Industriale
375
Subsidiary Investment Banks/Brokers 375
The University of Chicago Booth School of Business
131
College/University Other Consumer Services 131
58
Subsidiary Investment Banks/Brokers 58
Swarthmore College
37
College/University Other Consumer Services 37
32
Operating Division Investment Banks/Brokers 32
Public Company Biotechnology 26
Extinct Pharmaceuticals: Major 14
13
Private Company Investment Managers 13
7
Operating Division Investment Banks/Brokers 7
6
Extinct Biotechnology 6
Wasserstein Perella & Co., Inc.
6
Private Company 6
4
Extinct Investment Managers 4
2
Private Company Biotechnology 2

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Stephen Allen Hurly tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Biotechnology

Cary Pfeffer

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Peter Kiener

Arthur P. DeCillis

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Biotechnology

Abbie Celniker

Christy Oliger

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

David T. Molowa

Thomas Cannell

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Abbie Celniker

Mary Wadlinger

Chief Operating Officer

Human Resources Officer

ONCOTELIC THERAPEUTICS, INC. Biotechnology

David Chaplin

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Jamie Baker

David T. Molowa

R. Jeremy Metz

Analyst-Equity

Analyst-Equity

Analyst-Equity

Biotechnology

Glen C. MacDonald

Arthur P. DeCillis

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

FIVE PRIME THERAPEUTICS, INC. Biotechnology

Franklin Berger

Kapil Dhingra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Cary Pfeffer

Director/Board Member

Brown University College/University

Timothy Scheve

R. Jeremy Metz

Graduate Degree

Undergraduate Degree

The Trustees of Columbia University in The City of New York College/University

Joyce Chang

Cary Pfeffer

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Mark Sullivan

Cary Pfeffer

Undergraduate Degree

Doctorate Degree

GENMAB A/S Pharmaceuticals: Major

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

University of Oxford College/University

James Noble

Peter Kiener

Nathan Zibilich

Graduate Degree

Corporate Officer/Principal

Graduate Degree

College/University

Paul W. H. I. Parren

Corporate Officer/Principal

College/University

Erik Thomas Kahler

Dave Novosel

Rick Rick

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Indiana University College/University

Erick Lucera

Ted Manvitz

Masters Business Admin

Masters Business Admin

The Johns Hopkins University College/University

Franklin Berger

Ben Ramsey

Graduate Degree

Undergraduate Degree

New York University College/University

Steven Alexopoulos

Andrea Teixeira

Brett Marshall Reiss

Masters Business Admin

Masters Business Admin

Undergraduate Degree

The Pennsylvania State University College/University

Fred M. Powell

Amy Garabedian

Undergraduate Degree

Undergraduate Degree

Biotechnology

Abbie Celniker

Cary Pfeffer

Chairman

Director/Board Member

Princeton University College/University

Charles E. Mitchell Rentschler

Joyce Chang

Undergraduate Degree

Graduate Degree

Investment Managers

Abbie Celniker

Cary Pfeffer

Private Equity Investor

Private Equity Investor

Columbia Business School College/University

Reginald Smith

Peter Acciavatti

Masters Business Admin

Masters Business Admin

AUTOLUS THERAPEUTICS PLC Biotechnology

Jay Backstrom

Kapil Dhingra

Director/Board Member

Director/Board Member

University of Amsterdam College/University

Paul W. H. I. Parren

Hans van der Vliet

Doctorate Degree

Doctorate Degree

IMMUNOCORE HOLDINGS PLC Biotechnology

James Noble

Jessica Truscello

Founder

Chief Operating Officer

REPLIMUNE GROUP, INC. Biotechnology

Kapil Dhingra

Christy Oliger

Director/Board Member

Director/Board Member

University of Delaware College/University

Paul Chaney

Erick Lucera

Undergraduate Degree

Undergraduate Degree

Biotechnology

Erik van den Berg

Ton Adang

Director/Board Member

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Michael Minchak

Cary Pfeffer

Undergraduate Degree

Masters Business Admin

University of Vermont College/University

John J. McCabe

Robert Kramer

Undergraduate Degree

Doctorate Degree

Harvard Business School College/University

Franklin Berger

Karen Wilson

Masters Business Admin

Corporate Officer/Principal

The Leonard N Stern School of Business College/University

Michael Rehaut

Joseph Charles Dazio

Undergraduate Degree

Undergraduate Degree

Maurice A. Deane School of Law at Hofstra University College/University

Brett Marshall Reiss

Doctorate Degree

Biotechnology

Cary Pfeffer

Director/Board Member

Miscellaneous Commercial Services

Cary Pfeffer

Founder

Pharmaceuticals: Major

Cary Pfeffer

Director/Board Member

JOUNCE THERAPEUTICS, INC. Miscellaneous Commercial Services

Cary Pfeffer

Chief Executive Officer

Packaged Software

Cary Pfeffer

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 37
Regno Unito 4
Paesi Bassi 3
Canada 2
Danimarca 2

Settori

Consumer Services 20
Health Technology 18
Finance 6
Commercial Services 4
Technology Services 2

Posizioni

Director/Board Member 216
Corporate Officer/Principal 197
Analyst-Equity 75
Undergraduate Degree 60
Independent Dir/Board Member 55